Literature DB >> 35076003

Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong.

Elliott F Miot, Brian M Worthington, Kar Hon Ng, Lucy de Guilhem de Lataillade, Mac P Pierce, Yunshi Liao, Ronald Ko, Marcus H Shum, William Y Cheung, Edward C Holmes, Kathy S Leung, Huachen Zhu, Leo L Poon, Malik J Peiris, Yi Guan, Gabriel M Leung, Joseph T Wu, Tommy T Lam.   

Abstract

We report surveillance conducted in 217 pestiferous rodents in Hong Kong for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We did not detect SARS-CoV-2 RNA but identified 1 seropositive rodent, suggesting exposure to a virus antigenically similar to SARS-CoV-2. Potential exposure of urban rodents to SARS-CoV-2 cannot be ruled out.

Entities:  

Keywords:  COVID-19; China; Hong Kong; SARS-CoV-2; coronavirus disease; respiratory infections; rodents; serosurveillance; severe acute respiratory syndrome coronavirus 2; urban public health; viruses; zoonoses

Mesh:

Substances:

Year:  2022        PMID: 35076003      PMCID: PMC8798707          DOI: 10.3201/eid2802.211586

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China, in late 2019 () and soon spread globally. Although its zoonotic origin remains unclear, animal species potentially susceptible to reverse-zoonotic transmission from humans have been identified (e.g., cats, dogs, minks, deer), some of which (e.g., mink) might maintain the virus and pose a risk of future spillback to humans (,). Domestic animals and urban wildlife are of particular concern () because of their potential exposure to viruses shed within urban environments. Analysis of the angiotensin-converting enzyme 2 (ACE2) receptor across diverse vertebrates suggests a potentially wide breadth of SARS-CoV-2–susceptible mammal host species (). The rapid transmission and adaptation of SARS-CoV-2 in humans has been characterized by the evolution of variants of concern (VOCs). Several VOCs, particularly the Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) variants, have convergently evolved an amino acid residue change in the receptor binding domain of the spike protein (N501Y) that was also observed following serial passage of SARS-CoV-2 in BALB/c mice (). Recent in vitro and in vivo experiments have demonstrated that these VOCs are capable of infecting laboratory rats and mice (; Montagutelli X et al., unpub. data, https://doi.org/10.1101/2021.03.18.436013). Such evolutionary processes indicate a possible risk for reverse-zoonotic transmission of VOCs into urban rodents. We hypothesized that locations with positive SARS-CoV-2 detection in sewage could also serve as key surveillance targets for potential exposure of pestiferous urban rodents to SARS-CoV-2 shed into the environment. We conducted sewage surveillance in Hong Kong to identify hidden infections and localized outbreaks of SARS-CoV-2 () during the fourth wave of COVID-19 in Hong Kong (Appendix). During February 3–May 12, 2021, we sampled 217 rodents (Rattus spp.), 193 live-trapped rodents and 24 found dead near collection sites (Appendix Table 1). We collected 189 R. norvegicus and 28 R. tanezumi rats from 8 districts, the majority (n = 186) from Sham Shui Po, Yau Tsim Mong, and Kowloon City (Figure), where SARS-CoV-2 positive sewage has been reported.
Figure

Surveillance of rodents for SARS-COV-2 conducted February–May 2021 in Hong Kong. A) Sampling sites, with number of rodents sampled and sewage testing positive for SARS-COV-2. Each circle represents a sampling location, color-coded by district and sized proportional to the number of captured rodents. Blue crosses represent locations where sewage was reported positive for SARS-COV-2during January 19–March 30, 2021. B) Number of sampled rodents, by collection dates and district. SARS-COV-2, severe acute respiratory syndrome coronavirus 2

Surveillance of rodents for SARS-COV-2 conducted February–May 2021 in Hong Kong. A) Sampling sites, with number of rodents sampled and sewage testing positive for SARS-COV-2. Each circle represents a sampling location, color-coded by district and sized proportional to the number of captured rodents. Blue crosses represent locations where sewage was reported positive for SARS-COV-2during January 19–March 30, 2021. B) Number of sampled rodents, by collection dates and district. SARS-COV-2, severe acute respiratory syndrome coronavirus 2 We found samples from 1,702 swabs and tissues from 217 rats negative for SARS-CoV-2 by real-time quantitative PCR and 15 from 9 rats positive for murine alphacoronaviruses and betacoronaviruses using PCR and phylogenetic analysis (Appendix Table 2, Figure 1). Using ELISA, we identified 1 of 213 rodent serum samples from an R. norvegicus rat collected in Yau Ma Tei seropositive for SARS-CoV-2 (Table; Appendix Figure 2) and 11 samples inconclusive; only 1 of 2 replicates from 8 samples gave a positive absorbance result, and 1 or both replicates from 3 samples gave a borderline absorbance (Table; Appendix Figure 2). The unambiguously positive sample, from rat no. 213, was confirmed positive in surrogate virus neutralization testing (sVNT; 31.7% inhibition), but negative by plaque-reduction neutralization test (PRNT90; <10 titers for 90% reduction). All 11 inconclusive samples were negative (<20% inhibition) by sVNT. As a pre–COVID-19 biological control to test for cross-sensitivity, 50 rodent serum samples collected in 2008 were examined by ELISA; none exhibited an unambiguously positive result.
Table

Information on rodents with unambiguous (n = 1) or inconclusive (n = 11) positive serum samples in ELISA testing in study of surveillance of rodent pests for severe acute respiratory syndrome coronavirus 2 and other coronaviruses, Hong Kong*

Animal codeRattus speciesCollection dateDistrictELISA A/CO
sVNT, inhibition, %
1st replicate2nd replicate
Rat-027
R. tanezumi
Feb 11
Sham Shui Po
0.019
0.855
1.281
Rat-069
R. norvegicus
Feb 24
Kowloon City
0.837
0.964
0.991
Rat-070
R. norvegicus
Feb 24
Kowloon City
1.199
0.472
–2.128
Rat-073
R. tanezumi
Feb 25
Yau Tsim Mong
1.445
0.033
2.224
Rat-076
R. norvegicus
Feb 25
Sham Shui Po
1.644
0.027
1.136
Rat-089
R. norvegicus
Mar 1
Yau Tsim Mong
1.324
–0.041
1.209
Rat-090
R. norvegicus
Mar 1
Yau Tsim Mong
1.636
–0.027
–0.532
Rat-096
R. norvegicus
Mar 2
Yau Tsim Mong
0.934
–0.007
3.748
Rat-097
R. norvegicus
Mar 2
Yau Tsim Mong
1.592
0.013
–4.666
Rat-098
R. tanezumi
Mar 2
Sham Shui Po
1.920
–0.724
–2.466
Rat-102
R. norvegicus
Mar 3
Kwai Tsing
0.992
–0.499
0.145
Rat-213† R. norvegicus May 10Yau Tsim Mong13.64314.49731.7

*A/CO was interpreted as negative if <0.9, borderline if 0.9–1.1, and seropositive if >1.1, according to manufacturer instructions. Serum was considered unambiguously positive if both replicates were seropositive. Positive cutoff for sVNT was 20% inhibition, as described elsewhere (). A/CO, absorbance cutoff; sVNT, surrogate virus neutralization test. †Positive in both ELISA and sVNT.

*A/CO was interpreted as negative if <0.9, borderline if 0.9–1.1, and seropositive if >1.1, according to manufacturer instructions. Serum was considered unambiguously positive if both replicates were seropositive. Positive cutoff for sVNT was 20% inhibition, as described elsewhere (). A/CO, absorbance cutoff; sVNT, surrogate virus neutralization test. †Positive in both ELISA and sVNT. Our rodent surveillance in Hong Kong revealed potential exposure to SARS-CoV-2, and although viral RNA was not detected, this could be a limitation of sample size if prevalence of active infection was low. One serum sample showed positive ELISA and sVNT results but negative PRNT90 results. Previous research demonstrated that the sVNT used in our study has >98.8% specificity and sensitivity without cross-reaction to alphacoronaviruses and murine betacoronavirus (). Some sVNT-positive COVID-19–confirmed patients did not meet the threshold for positivity by PRNT90 (). This finding suggests that the seropositive result for SARS-CoV-2 or a closely related virus in the brown rat was unlikely to be attributable to past exposure to murine alphacoronaviruses or betacoronaviruses. During our study period, SARS-CoV-2 infection was reported in several imported and local human cases in multiple locations and in multiple sewage results. Before December 2020, SARS-CoV-2 locally circulating in Hong Kong predominantly carried 501N with presumably lower rodent infectivity; however, during our study period, Hong Kong reported many imported cases of SARS-CoV-2 variants, including B.1.1.7 and B.1.351, carrying 501Y, which has been demonstrated in mouse experiments to be a critical genetic adaptation (). These imported cases might disseminate virus into the environment near quarantine hotels, presenting an increased risk of spillover into urban rodent populations and requiring enhanced biosecurity to limit potential exposure to urban rodents or other susceptible animals. Our finding of potential SARS-CoV-2 exposure in a pestiferous rat highlights the need for sustained monitoring of rodent populations to rapidly detect spillover events and subsequently put in place timely interventions (e.g., disinfestation using trapping and pesticide) to prevent potential establishment of new reservoirs.

Appendix

Additional information on surveillance of rodents for severe acute respiratory syndrome coronavirus 2 in Hong Kong.
  9 in total

1.  Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera.

Authors:  Ranawaka A P M Perera; Ronald Ko; Owen T Y Tsang; David S C Hui; Mike Y M Kwan; Christopher J Brackman; Esther M W To; Hui-Ling Yen; Kathy Leung; Samuel M S Cheng; Kin Ho Chan; Karl C K Chan; Ka-Chi Li; Linda Saif; Vanessa R Barrs; Joseph T Wu; Thomas H C Sit; Leo L M Poon; Malik Peiris
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

2.  Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.

Authors:  Joana Damas; Graham M Hughes; Kathleen C Keough; Corrie A Painter; Nicole S Persky; Marco Corbo; Michael Hiller; Klaus-Peter Koepfli; Andreas R Pfenning; Huabin Zhao; Diane P Genereux; Ross Swofford; Katherine S Pollard; Oliver A Ryder; Martin T Nweeia; Kerstin Lindblad-Toh; Emma C Teeling; Elinor K Karlsson; Harris A Lewin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-21       Impact factor: 11.205

3.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

4.  Emerging SARS-CoV-2 variants expand species tropism to murines.

Authors:  Huiping Shuai; Jasper Fuk-Woo Chan; Terrence Tsz-Tai Yuen; Chaemin Yoon; Jing-Chu Hu; Lei Wen; Bingjie Hu; Dong Yang; Yixin Wang; Yuxin Hou; Xiner Huang; Yue Chai; Chris Chung-Sing Chan; Vincent Kwok-Man Poon; Lu Lu; Rui-Qi Zhang; Wan-Mui Chan; Jonathan Daniel Ip; Allen Wing-Ho Chu; Ye-Fan Hu; Jian-Piao Cai; Kwok-Hung Chan; Jie Zhou; Siddharth Sridhar; Bao-Zhong Zhang; Shuofeng Yuan; Anna Jinxia Zhang; Jian-Dong Huang; Kelvin Kai-Wang To; Kwok-Yung Yuen; Hin Chu
Journal:  EBioMedicine       Date:  2021-10-21       Impact factor: 8.143

5.  The first case study of wastewater-based epidemiology of COVID-19 in Hong Kong.

Authors:  Xiaoqing Xu; Xiawan Zheng; Shuxian Li; Nga Sze Lam; Yulin Wang; Daniel K W Chu; Leo L M Poon; Hein Min Tun; Malik Peiris; Yu Deng; Gabriel M Leung; Tong Zhang
Journal:  Sci Total Environ       Date:  2021-05-24       Impact factor: 7.963

6.  Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.

Authors:  Bas B Oude Munnink; Reina S Sikkema; David F Nieuwenhuijse; Robert Jan Molenaar; Emmanuelle Munger; Richard Molenkamp; Arco van der Spek; Paulien Tolsma; Ariene Rietveld; Miranda Brouwer; Noortje Bouwmeester-Vincken; Frank Harders; Renate Hakze-van der Honing; Marjolein C A Wegdam-Blans; Ruth J Bouwstra; Corine GeurtsvanKessel; Annemiek A van der Eijk; Francisca C Velkers; Lidwien A M Smit; Arjan Stegeman; Wim H M van der Poel; Marion P G Koopmans
Journal:  Science       Date:  2020-11-10       Impact factor: 47.728

7.  Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

Authors:  Hongjing Gu; Qi Chen; Guan Yang; Lei He; Hang Fan; Yong-Qiang Deng; Shibo Jiang; Shihui Sun; Cheng-Feng Qin; Yusen Zhou; Yanxiao Wang; Yue Teng; Zhongpeng Zhao; Yujun Cui; Yuchang Li; Xiao-Feng Li; Jiangfan Li; Na-Na Zhang; Xiaolan Yang; Shaolong Chen; Yan Guo; Guangyu Zhao; Xiliang Wang; De-Yan Luo; Hui Wang; Xiao Yang; Yan Li; Gencheng Han; Yuxian He; Xiaojun Zhou; Shusheng Geng; Xiaoli Sheng
Journal:  Science       Date:  2020-07-30       Impact factor: 47.728

8.  Peridomestic Mammal Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Angela M Bosco-Lauth; J Jeffrey Root; Stephanie M Porter; Audrey E Walker; Lauren Guilbert; Daphne Hawvermale; Aimee Pepper; Rachel M Maison; Airn E Hartwig; Paul Gordy; Helle Bielefeldt-Ohmann; Richard A Bowen
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883

  9 in total
  1 in total

1.  Optimizing Strategies for Improving Mental Health in Victoria, Australia during the COVID-19 Era: A System Dynamics Modelling Study.

Authors:  Catherine Vacher; Nicholas Ho; Adam Skinner; Jo Robinson; Louise Freebairn; Grace Yeeun Lee; Frank Iorfino; Ante Prodan; Yun Ju C Song; Jo-An Occhipinti; Ian B Hickie
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.